Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Carbone

Showing results (81-90 of 283) with videos related to

Pageof 29
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2018
Co-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in NSCLCSara L Sinicropi-Yao, Joseph M Amann, David Lopez Y Lopez, et al.
Cold Spring Harbor Perspectives in Medicine|September 28, 2021
Lung Cancer Stem Cells and Their Clinical ImplicationsSamuel P Rowbotham, Mounika U L Goruganthu, Rajeswara R Arasada, et al.
Ebiomedicine|December 24, 2017
Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung AdenocarcinomaMichael F Sharpnack, Bin Chen, Dvir Aran, et al.
Blood|February 15, 2003
VEGF inhibits T-cell development and may contribute to tumor-induced immune suppressionJoyce E Ohm, Dmitry I Gabrilovich, Gregory D Sempowski, et al.
Clinical Lung Cancer|June 11, 2018
Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective StudyMarisa A Bittoni, Ashwini Arunachalam, Haojie Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Prognostic and predictive role of the VeriStrat plasma test in patients with advanced non-small-cell lung cancer treated with erlotinib or placebo in the NCIC Clinical Trials Group BR.21 trialDavid P Carbone, Keyue Ding, Heinrich Roder, et al.
Cancer Research|May 4, 2005
Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancersNobuhiro Haruki, Keiko S Kawaguchi, Shannon Eichenberger, et al.
Chest|May 12, 2004
Role of p63 amplification and overexpression in lung cancer developmentPierre P Massion, Peter M Taflan, S M Jamshedur Rahman, et al.
Neoplasia (New York, N.Y.)|August 21, 2008
Host A(2B) adenosine receptors promote carcinoma growthSergey Ryzhov, Sergey V Novitskiy, Rinat Zaynagetdinov, et al.
Oncotarget|October 3, 2015
Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalkMenaka C Thounaojam, Duafalia F Dudimah, Samuel T Pellom, et al.
Pageof 29

Showing results (81-90 of 283) with videos related to

Sort By:
Pageof 29
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2018
Co-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in NSCLCSara L Sinicropi-Yao, Joseph M Amann, David Lopez Y Lopez, et al.
Cold Spring Harbor Perspectives in Medicine|September 28, 2021
Lung Cancer Stem Cells and Their Clinical ImplicationsSamuel P Rowbotham, Mounika U L Goruganthu, Rajeswara R Arasada, et al.
Ebiomedicine|December 24, 2017
Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung AdenocarcinomaMichael F Sharpnack, Bin Chen, Dvir Aran, et al.
Blood|February 15, 2003
VEGF inhibits T-cell development and may contribute to tumor-induced immune suppressionJoyce E Ohm, Dmitry I Gabrilovich, Gregory D Sempowski, et al.
Clinical Lung Cancer|June 11, 2018
Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective StudyMarisa A Bittoni, Ashwini Arunachalam, Haojie Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Prognostic and predictive role of the VeriStrat plasma test in patients with advanced non-small-cell lung cancer treated with erlotinib or placebo in the NCIC Clinical Trials Group BR.21 trialDavid P Carbone, Keyue Ding, Heinrich Roder, et al.
Cancer Research|May 4, 2005
Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancersNobuhiro Haruki, Keiko S Kawaguchi, Shannon Eichenberger, et al.
Chest|May 12, 2004
Role of p63 amplification and overexpression in lung cancer developmentPierre P Massion, Peter M Taflan, S M Jamshedur Rahman, et al.
Neoplasia (New York, N.Y.)|August 21, 2008
Host A(2B) adenosine receptors promote carcinoma growthSergey Ryzhov, Sergey V Novitskiy, Rinat Zaynagetdinov, et al.
Oncotarget|October 3, 2015
Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalkMenaka C Thounaojam, Duafalia F Dudimah, Samuel T Pellom, et al.
Pageof 29